Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest National Institute of Allergy and Infectious Diseases Stories

2012-02-03 11:42:18

Unpredictable, ever-changing and with potentially far-reaching effects on the fates of nations, infectious diseases are compelling actors in the drama of human history, note scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. In an essay marking 200 years of publication of the New England Journal of Medicine, NIAID Director Anthony S. Fauci, M.D., and coauthor David M. Morens, M.D., trace key advances in understanding...

2012-01-31 08:00:00

Aeras leverages U.S. government clinical trial networks designed for HIV research to support TB vaccine development ROCKVILLE, Md., Jan. 31, 2012 /PRNewswire-USNewswire/ -- Aeras announces today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), has joined as a partner for a Phase II proof-of-concept clinical trial of a tuberculosis vaccine candidate jointly developed by Aeras and Dutch...

2012-01-12 11:35:42

Genetic mutation leads to cold allergy, immune deficiency and autoimmunity Investigators at the National Institutes of Health have identified a genetic mutation in three unrelated families that causes a rare immune disorder characterized by excessive and impaired immune function. Symptoms of this condition include immune deficiency, autoimmunity, inflammatory skin disorders and cold-induced hives, a condition known as cold urticaria. The study was led by Joshua Milner, M.D., in the...

Experimental Potential HIV Vaccine Proves Promising In Monkeys
2012-01-05 10:02:23

An experimental vaccine tested in rhesus monkeys helped protect them from getting infected with Simian Immunodeficiency Virus (SIV) -- the primate version of HIV and AIDS -- and appears to make the disease more manageable in those who aren´t protected, researchers reported on Wednesday. The vaccine reduced the risk of infection by 80 percent among the monkeys exposed to SIV, while monkeys that became infected had lower amounts of the virus in their blood, the research team reported in...

2011-12-23 01:27:51

NIH-funded treatment-as-prevention study heralded as a major advance The journal Science has chosen the HPTN 052 clinical trial (http://www.niaid.nih.gov/news/newsreleases/2011/Pages/HPTN052.aspx), an international HIV prevention trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, as the 2011 Breakthrough of the Year. The study found that if HIV-infected heterosexual individuals begin taking antiretroviral...

2011-12-22 13:00:00

CHAPEL HILL, N.C., Dec. 22, 2011 /PRNewswire/ -- The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, M.D. of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science. To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/53909-unc-hiv-prevention-research-scientific-breakthrough-of-year (Photo: http://photos.prnewswire.com/prnh/20111222/MM26343 ) HPTN 052...

2011-12-14 12:30:00

MENLO PARK, Calif., Dec. 14, 2011 /PRNewswire/ -- SRI International has been awarded a contract worth up to $100.5 million over 10 years from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). This new award will allow SRI to continue a program that supports NIAID's Division of Microbiology and Infectious Diseases (DMID) in the translation of basic research into clinical applications. Since 2006, SRI has worked on more...

2011-11-18 03:52:02

New class of compounds would target earliest stages of infection Researchers have discovered a group of chemical compounds that might one day be developed into drugs that can treat malaria infection in both the liver and the bloodstream. The study, which appears in the Nov. 18 issue of Science, was led by Elizabeth A. Winzeler, Ph.D., of the Scripps Research Institute in La Jolla, Calif., and was partially funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of...

2011-11-16 09:52:07

Influenza researchers have found that flu strains migrate back and forth between different regions of the world, evolving along the way. This is contrary to the common belief that flu strains from the tropics are the source of global seasonal epidemics. The research appeared online on Nov. 14 in the Proceedings of the National Academy of Sciences. It was supported in part by the Centers of Excellence for Influenza Research and Surveillance and the Influenza Genome Sequencing Project,...

2011-11-02 21:56:47

Vaccine could prevent mononucleosis and cancers linked to virus Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes. Infections in early childhood often cause no disease symptoms, but people infected during adolescence or young adulthood may develop infectious mononucleosis, a disease characterized by swollen lymph nodes, fever and severe fatigue. EBV also is associated with several kinds of cancer, including Hodgkin lymphoma and stomach...